InvestorsHub Logo
Followers 481
Posts 60471
Boards Moderated 18
Alias Born 09/20/2001

Re: Whatsupp post# 10670

Tuesday, 05/21/2019 3:31:04 PM

Tuesday, May 21, 2019 3:31:04 PM

Post# of 21531
The TGA thinks the P2a was valid...

All that is needed is confirmation of previous results for provisional approval.

No safety issues. Cost is not an issue and the data will be for three different CNS indications so Drs will prescribe it for more than confirmed Alzheimer's.

When the Aussies approve it your opinion will be shown to be erroneous.

By the way, I never said the NTRP AD trial wouldn't pass the FDA's test. The FDA uses a trial format that hasn't been updated since the '40s, so who cares?




In Peace, In War

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News